Navigation Links
Prometheus Acquires Exclusive Rights to PROLEUKIN(R) (aldesleukin) in the U.S.
Date:1/26/2010

tricular), angina, myocardial infarction, respiratory insufficiency requiring intubation, gastrointestinal bleeding or infarction, renal insufficiency, edema, and mental status changes.

Proleukin treatment is associated with impaired neutrophil function (reduced chemotaxis) and with an increased risk of disseminated infection, including sepsis and bacterial endocarditis. Consequently, preexisting bacterial infections should be adequately treated prior to initiation of Proleukin therapy. Patients with indwelling central lines are particularly at risk for infection with gram positive microorganisms. Antibiotic prophylaxis with oxacillin, nafcillin, ciprofloxacin, or vancomycin has been associated with a reduced incidence of staphylococcal infections.

Proleukin administration should be withheld in patients developing moderate to severe lethargy or somnolence; continued administration may result in coma.

About Interleukin-2

Interleukin-2 (IL-2) is a protein that occurs naturally in the body and plays an important role in activating the immune system. The immune system protects the body from foreign substances, cells, and tissues by responding to and resisting diseases. Proleukin therapy is a genetically engineered or recombinant version of IL-2. Proleukin therapy possesses the same properties as naturally occurring IL-2 and helps activate the immune system to recognize and eliminate certain kinds of cancer cells.

About Prometheus

Prometheus Laboratories Inc. is committed to improving lives through the development and commercialization of novel pharmaceutical and diagnostic products that enable physicians to provide greater individualized patient care. Prometheus is a leader in applying the principles of personalized medicine to the diagnosis and treatment of gastrointestinal diseases and is applying these principles to oncology. Its strategy includes the marketing and delivery
'/>"/>

SOURCE Prometheus Laboratories Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Prometheus Launches ProOnc Dx Cancer Diagnostics
2. Prometheus Announces New Findings Regarding Patients at Risk for Celiac Disease at DDW
3. Prometheus and Rosetta Genomics Announce License and Collaboration Agreement
4. Prometheus Presents Findings From Development of PROMETHEUS(R) IBS Diagnostic, First Blood Test for IBS, at ACG Annual Scientific Meeting
5. Home Medical Equipment Supplier ActivStyle, Inc. Acquires Tampa-Based Advocate Medical Services, Inc.
6. QIAGEN Acquires ESE GmbH
7. Clarient Acquires Applied Genomics, Inc.
8. InterFlex Acquires C&H Packaging From Appleton Paper
9. University of Virginia Acquires New Elekta Technology to Expand Patient Groups That Could Benefit From Gamma Knife Surgery
10. Pharmaceutical Institute Acquires E-Learning Assets from GeneEd, Inc.
11. St. Lukes Hospital Acquires Pioneering Technology From BrainLAB
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/31/2015)... 31, 2015 RnRMarketResearch.com adds ... research report of 68 pages with latest updates, ... library. The report "Pemphigus - Pipeline Review, H1 ... therapeutic development for Pemphigus , complete with comparative ... target, mechanism of action (MoA), route of administration ...
(Date:3/31/2015)... N.C. , March 31, 2015  Dr. Renu ... be attending the World Orphan Drug Congress in April to ... regulatory approval process and orphan drugs below: ... has recommended to the Ministry of Health that if a ... marketing authorization can be obtained in India ...
(Date:3/31/2015)...   Halyard Health (NYSE: HYH ), ... a new purchasing agreement with HealthTrust for ... 2015, Halyard,s standard and ASTM-rated face masks , ... available to HealthTrust members made up of 1,350 acute ... physician practices and alternate care facilities. ...
Breaking Medicine Technology:Pemphigus Therapeutic Development and Pipeline Review H1 2015 2Pemphigus Therapeutic Development and Pipeline Review H1 2015 3Pemphigus Therapeutic Development and Pipeline Review H1 2015 4Max Neeman to Discuss India's Orphan Drug Regulations at WOD 2015 2Halyard Health Signs First GPO Contracts As Independent Company 2Halyard Health Signs First GPO Contracts As Independent Company 3
(Date:4/1/2015)... West Orange, NJ (PRWEB) April 01, 2015 ... seem as important as just finding some relief. Identifying the ... determining a solution. In many cases, the cause of chronic ... even more common than other diagnosable causes of back pain ... MD, PhD , founder and president of Atlantic Spine ...
(Date:4/1/2015)... 01, 2015 On April 1st, 2015, Dr. Jason ... guest on Better TV to discuss the epidemic known as “Text ... on the varying angle in which it is bent forward, such ... on the cervical spine can cause poor posture often times leading ... and more people spend hours on their cell phone device emailing, ...
(Date:4/1/2015)... Results are in for the fifth annual ... homes from across the state exemplifying high-efficiency design. Participants ... techniques and new technology intended to lower energy use ... provided sustainability consulting services for 4 of the 11 ... and third-place winners. , The Benker Residence, a four-bedroom ...
(Date:4/1/2015)... Coast, Florida (PRWEB) April 01, 2015 ... the 6th Annual Essentials in Primary Care Summer CME ... Kiawah Island Golf Resort. The conference features ... , The Essentials in Primary Care Summer Conference Session ... rapidly changing therapeutic areas. The emphasis is on practical and ...
(Date:4/1/2015)... Jacksonville, Florida (PRWEB) April 01, 2015 ... eighth-annual MSPmentor 501 Global Edition, a distinguished list ... service providers (MSPs). The complete 501 list is ... ,     The top ranked MSPs in ... Europe, Middle East and Africa ,     The ...
Breaking Medicine News(10 mins):Health News:Demystifying Facet Joint Syndrome 2Health News:Demystifying Facet Joint Syndrome 3Health News:Demystifying Facet Joint Syndrome 4Health News:Dr. Jason Helfrich, Co-Founder of 100% Chiropractic, is a Guest on Better TV to Discuss “Text Neck” 2Health News:Steven Winter Associates’ Projects Receive Top Honors in CT Zero Energy Challenge 2Health News:Steven Winter Associates’ Projects Receive Top Honors in CT Zero Energy Challenge 3Health News:Steven Winter Associates’ Projects Receive Top Honors in CT Zero Energy Challenge 4Health News:Primary Care Continuing Medical Education Conference (CME) Faculty Listing Released for the 6th Annual Essentials in Primary Care Conference on Kiawah Island, SC. 2Health News:Primary Care Continuing Medical Education Conference (CME) Faculty Listing Released for the 6th Annual Essentials in Primary Care Conference on Kiawah Island, SC. 3Health News:Primary Care Continuing Medical Education Conference (CME) Faculty Listing Released for the 6th Annual Essentials in Primary Care Conference on Kiawah Island, SC. 4Health News:Penton Technology Names Enterprise Integration to the MSPmentor 501 Global Edition 2Health News:Penton Technology Names Enterprise Integration to the MSPmentor 501 Global Edition 3
... advanced head and neck cancers who successfully complete treatment ... losing the ability to speak clearly and swallow comfortably, ... "This is good news," said Joseph K. Salama, MD, ... the corresponding author of the study. "I hope it ...
... surgery for upper airway and digestive track malignant tumors ... based on patient function and survival, according to University ... squamous cell carcinomas account for about 4 percent of ... Currently the standard minimally invasive surgery for these tumors ...
... Reporter , MONDAY, Dec. 20 (HealthDay News) -- Leading ... heart rate control in patients with atrial fibrillation, an ... More lenient management of the condition is safe for ... the American College of Cardiology and the American Heart ...
... , MONDAY, Dec. 20 (HealthDay News) -- ... swallow after undergoing combined chemotherapy and radiation treatment, but ... have found. The new study included patients who ... treated with chemoradiotherapy for advanced head and neck cancer. ...
... (HealthDay News) -- People with psoriasis are at increased ... as metabolic syndrome, a new study has found. ... high blood pressure, diabetes and high total cholesterol and ... Psoriasis is a common skin problem caused by a ...
... contract disputes, a new book by a Queen,s University law ... In the wake of well-publicised disputes, such as Wayne ... of Liverpool FC, Modern Sports Law examines the relationship between ... Lecturer at Queen,s School of Law, the book is one ...
Cached Medicine News:Health News:Factors linked to speech/swallowing problems after treatment for head and neck cancers 2Health News:Robotic surgery for head and neck cancer shows promise 2Health News:Guidelines Eased for Patients With Irregular Heartbeats 2Health News:Guidelines Eased for Patients With Irregular Heartbeats 3Health News:Speech, Swallowing Usually OK After Head & Neck Cancer Therapy 2Health News:Psoriasis Linked to Raised Heart Risks 2Health News:Playing by the rules? New book examines relationship between law and sport 2Health News:Playing by the rules? New book examines relationship between law and sport 3
Varicella-zoster virus (VZV) IgM Enzyme-Linked Immunosorbent Assay (ELISA) is intended for the detection of IgM antibody to Varicella-zoster virus in human serum as an aid in the diagnosis of primar...
... Mumps IgG ELISA test system is intended ... antibody in human serum. When performed according ... test, together with other clinical information, may ... and/or aid in the diagnosis of Mumps ...
... Mumps IgG Enzyme-linked Immunosorbent Assay (ELISA) is ... of IgG antibody to Mumps virus in ... used for the determination of immune status. ... used to demonstrate seroconversion or a significant ...
... TEG system is comprised of the TEG analyzer ... a complete picture of the formation and dissolution ... of the two systems. ,Haemoscope's TEG analyzer is ... that follows the reliable and proven model developed ...
Medicine Products: